Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients.
- DOI
- 10.1186/s12872-025-05316-0
- Published
- 2025 Dec 29
- Container
- BMC cardiovascular disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12872-025-05316-0,
title = {Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients.},
author = {Esteban-Fernández A and López-Fernández S and Pastor-Pérez FJ and Pérez-Rivera JÁ and Bonilla-Palomas JL and Cobo-Marcos M and García-Pinilla JM and Almenar-Bonet L and Fluviá-Brugués P and Bermúdez-Jiménez FJ and Goena-Vives C and López-López A and Gómez-Otero I and TIDY-HF researchers},
year = {2025},
journal = {BMC cardiovascular disorders},
doi = {10.1186/s12872-025-05316-0},
url = {https://doi.org/10.1186/s12872-025-05316-0}
}RIS
TY - JOUR TI - Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients. AU - Esteban-Fernández A AU - López-Fernández S AU - Pastor-Pérez FJ AU - Pérez-Rivera JÁ AU - Bonilla-Palomas JL AU - Cobo-Marcos M AU - García-Pinilla JM AU - Almenar-Bonet L AU - Fluviá-Brugués P AU - Bermúdez-Jiménez FJ AU - Goena-Vives C AU - López-López A AU - Gómez-Otero I AU - TIDY-HF researchers PY - 2025 JO - BMC cardiovascular disorders DO - 10.1186/s12872-025-05316-0 UR - https://doi.org/10.1186/s12872-025-05316-0 ER -
APA
A, E., S, L., FJ, P., JÁ, P., JL, B., M, C., JM, G., L, A., P, F., FJ, B., C, G., A, L., I, G., & researchers, T. (2025). Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients.. BMC cardiovascular disorders. https://doi.org/10.1186/s12872-025-05316-0
Source records
- pubmed · retrieved 2026-09-26T19:48:05.297Z